Equity intelligence report • July 05, 2026
Baxter International continues to face significant financial turmoil, highlighted by a substantial 9% drop in share value after the latest earnings report fell short of expectations. The company reported revenue of $3.75 billion for Q2 2022, missing forecasts, as ongoing operational challenges dampen investor confidence. This follows a series of downgrades from major banks due to ongoing profit forecasts cuts and a marked decline in stock value, stemming from a combination of operational issues, legal troubles over defective product sales, and leadership changes aimed at stabilizing the business. Despite committing to sustainability initiatives and launching new products, Baxter's financial outlook remains troubled amidst severe revenue losses and negative market sentiment.
Click a month on the chart to update the report below.
